Literature DB >> 6941627

Dicarboxylic aciduria during ketotic phases in various types of glycogen storage disease.

J E Pettersen, A Winsnes.   

Abstract

Urine samples were collected before and after a starvation period of 14-16 h from patients with glycogen storage disease, one with type III (amylo-1,6-glucosidase deficiency), four with type VIII (phosphorylase-b-kinase deficiency), and one with an unclassified type. The excretion of adipic, suberic, and 3-hydroxybutyric acid was measured by combined gas chromatography-mass spectrometry. The tendency towards ketosis seemed to decline with age in the patients with type VIII. In the non-ketotic patients no excess amounts of dicarboxylic acids were excreted. Therefore, glycogen storage disease per se seems to have no direct relationship to the excretion of adipic or suberic acid. A positive correlation was, however, found between the urinary excretion of on one side 3-hydroxybutyric and on the other adipic (correlation coefficient (Kendall's tau) +0.64, P less than 0.002 (one-sided test)) or suberic (+0.61, P less than 0.003) acid. The two dicarboxylic acids are most probably formed from long-chain monocarboxylic acids by omega- and beta-oxidation. It is speculated that succinyl-CoA formed by this pathway may counteract the tendency to ketosis in patients with glycogen storage disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941627     DOI: 10.1111/j.1651-2227.1981.tb16557.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  2 in total

1.  Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.

Authors:  Hironori Nagasaka; Ken-ichi Hirano; Akira Ohtake; Takashi Miida; Tomozumi Takatani; Kei Murayama; Tohru Yorifuji; Kunihiko Kobayashi; Masaki Kanazawa; Atsushi Ogawa; Masaki Takayanagi
Journal:  Eur J Pediatr       Date:  2007-01-06       Impact factor: 3.183

2.  Dicarboxylicaciduria and secondary carnitine deficiency in glycogenosis type IV.

Authors:  P D Maaswinkel-Mooy; B J Poorthuis; H H van Gelderen; J J van de Kamp
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.